Stephan Moll, MD, professor of medicine in the division of hematology, is quoted in a new Physicians Weekly article that recognizes anticoagulents in patients hospitalized with COVID “appeared to improve hospital survival times both in and out of the ICU, in an analysis of outcomes among more than 2,700 cases treated within the Mount Sinai Health System in New York City.”
Moll acknowledges the data as promising but says the issue still has discrepant published data. Still, he thinks the general impression by a number of clinicians and academicians, including himself, is that a somewhat more aggressive anticoagulation strategy in Covid-19 patients may be warranted.
In the article, Moll also recognizes that UNC Medical Center has adopted an “intermediate anticoagulation intensity approach coupled with reviewing new publications and adjusting the algorithm to newly release data.”
Read the article here.